stockrow
Friday 6 November 2026
Export SNYRQ’s income statement to Excel — free account
Synergy CHC Corp.
SNYRQ Healthcare Medical Distribution
Synergy CHC Corp.’s revenue for fiscal 2025 (year ended December 2025) was $30.4 million, down 12.8% from fiscal 2024.
- Revenue
- −32.8%
- EPS
- −330.0%
- Free cash flow
- −148.5%
- Total debt
- +7.08%
Quarter to March 2026, against a year earlier
0.00
0.00
NaN
Follow SNYRQ
Alert me
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
P/E ratio |
0.02 | 0.02 | 15.85 | 0.00 |
Piotroski F-Score |
— | — | 3 | 2 |
Altman Z-Score |
— | — | 0.05 | (7.00) |
P/S ratio |
0.00 | 0.00 | 0.96 | 0.60 |
Altman Z″-Score (non-manufacturers) |
(23.57) | (8.28) | (7.39) | (23.28) |
P/FCF ratio |
0.04 | 0.04 | 0.00 | 0.00 |
P/Operating CF |
0.00 | (0.31) | (9.75) | 28.98 |
Beneish M-Score |
— | (0.60) | 0.60 | (7.98) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.81 | 1.50 | 1.33 |
EV/EBITDA |
0.00 | 4.27 | 8.74 | 0.00 |
EV/Operating CF |
0.00 | 16.16 | (10.91) | (15.67) |
EV/FCF |
0.00 | 16.16 | (10.91) | (15.67) |
Quick Ratio |
0.34 | 0.52 | 0.73 | 0.72 |
Current Ratio |
0.61 | 0.84 | 0.93 | 1.22 |
Net Debt/EBITDA |
(0.79) | 2.28 | 3.17 | (3.35) |
Debt/Assets |
117.68% | 208.53% | 121.09% | 247.50% |
Debt/Equity |
(0.65) | (0.93) | (1.19) | (1.09) |
Asset Turnover |
0.00 | 2.78 | 2.44 | 2.29 |
Operating CF/Net income |
0.26 | 0.07 | (2.26) | 0.21 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(4.06) | 2.55 | 1.41 | (1.43) |
| 0.00% | (20.84%) | (9.67%) | 62.08% | |
| 0.00% | 41.19% | 14.87% | (93.11%) | |
ROIC |
0.00% | 0.00% | 152.93% | 0.00% |
Return on Tangible Assets |
278.41% | (288.26%) | (188.96%) | (693.99%) |
Average Days of Receivables |
75.14 | 56.03 | 122.55 | 38.49 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
98.15% | 49.65% | 50.84% | 72.31% |
Intangible Assets out of Total Assets |
0.00 | 0.03 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.28% | 3.66% |
Graham Net Nets |
0.00 | (345.62) | (0.51) | (1.29) |
Graham Number |
0.00 | 0.00 | 0.00 | 7.57 |
Earnings Yield |
4,376.00% | 4,376.00% | 6.31% | (57.53%) |
Free Cash Flow Yield |
2,417.01% | 2,417.01% | (14.39%) | (14.29%) |
Revenue per Share |
5.08 | 5.80 | 4.59 | 3.12 |
Operating CF per Share |
(1.12) | 0.06 | (0.63) | (0.27) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(1.12) | 0.06 | (0.63) | (0.27) |
Cash per Share |
0.33 | 0.10 | 0.10 | 0.28 |
Shareholders Equity per Share |
(4.44) | (3.70) | (2.19) | (2.38) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(4.44) | (3.70) | (2.19) | (2.38) |
Free Cash Flow |
(8.43) | 0.42 | (4.80) | (2.58) |
Working Capital |
(11.72) | (2.20) | (1.12) | 1.78 |
Net Current Asset Value |
(33.52) | (27.72) | (16.91) | (23.28) |
EV/EBIT |
0.00 | 4.37 | 9.03 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.01 | 0.01 | 5.76 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
91.91% | (40.17%) | (121.71%) | (54.41%) |
Accounts Receivable Turnover |
0.00 | 5.91 | 3.82 | 4.08 |
Accounts Payable Turnover |
0.00 | 0.66 | 1.32 | 1.74 |
Inventory Turnover |
0.00 | 1.83 | 4.11 | 3.70 |
Average Days of Payables |
302.28 | 400.15 | 169.33 | 231.36 |
Days of Inventory on Hand |
115.81 | 127.14 | 55.99 | 135.36 |
Average Receivables |
— | 7.24 | 9.13 | 7.45 |
Average Payables |
— | 16.26 | 8.46 | 5.79 |
Average Inventory |
— | 5.85 | 2.72 | 2.73 |
Average Assets |
— | 15.39 | 14.29 | 13.25 |
Average Common Equity |
— | (30.41) | (21.97) | (19.88) |
Columns are period end dates